Your session is about to expire
← Back to Search
Buprenorphine for Opioid Use Disorder
Study Summary
This trial will compare the effectiveness of a medication given to people on probation or parole to the usual referral to a community treatment program.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 65 years old.I can understand and pass a quiz about the study.I am currently using benzodiazepines, like Valium or Xanax.I do not have current psychosis or thoughts of harming myself.
- Group 1: BBT
- Group 2: TAU
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many volunteers will be included in this experiment?
"Presently, this study is not looking for new participants as the last recruitment drive was on August 18th, 2021. The trial was first posted on March 1st, 2019. There are other clinical trials you may be eligible for if you search for studies involving opioids use (146 active trials) or Buprenorphine/Naloxone (60 active trials)."
Are any minors participating in this research project?
"According to the inclusion criteria, this particular trial is only for patients aged 18-65. However, there are 19 trials available for minors and 173 options for elderly patients."
Has Buprenorphine/Naloxone been cleared by the FDA?
"There is some evidence from Phase 3 clinical trials to support the efficacy of Buprenorphine/Naloxone, as well as multiple rounds of data collected in order to assess safety. Consequently, our team has rated the safety of this medication a 3."
What is the evidence for Buprenorphine/Naloxone's efficacy?
"There are currently 60 clinical trials underway that focus on Buprenorphine/Naloxone. Of those, 14 have advanced to Phase 3 testing. Although the majority of these trials take place in White River Junction, Vermont, there are a total of 243 locations running similar research."
Are there any medical conditions which would make a person ineligible for this clinical trial?
"Candidates for this study must have a history of opioid use and be between the ages 18-65. Only 320 participants will be accepted in total."
Are there any unfilled vacancies for candidates in this experiment?
"This specific clinical trial, as indicated by the most recent update on clinicaltrials.gov, is not enrolling patients at this time. The study was first posted on March 1st, 2019 and last edited on August 18th, 2021. There are 206 other trials that are actively recruiting patients right now."
Share this study with friends
Copy Link
Messenger